Heterogeneity of response to biologic treatment: perspective for psoriasis (Q39371287)

11 September 2017

title

Heterogeneity of response to biologic treatment: perspective for psoriasis (English)

1 reference

11 September 2017

1 reference

Emily Edson-Heredia

1

1 reference

11 September 2017

Kimberly L Sterling

2

1 reference

11 September 2017

Carlos I Alatorre

3

1 reference

11 September 2017

Gebra Cuyun Carter

4

1 reference

11 September 2017

Rosirene Paczkowski

5

1 reference

11 September 2017

Victoria Zarotsky

6

1 reference

11 September 2017

Tomoko Maeda-Chubachi

7

1 reference

11 September 2017

language of work or name

English

0 references

publication date

6 August 2013

1 reference

Journal of Investigative Dermatology

11 September 2017

published in

1 reference

11 September 2017

volume

134

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

18-23

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2013.326

11 September 2017

exact match

0 references

cites work

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.

1 reference

12 December 2020

Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome

1 reference

12 December 2020

Low-dose etanercept therapy in moderate to severe psoriasis in Korean.

1 reference

12 December 2020

Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages

1 reference

12 December 2020

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis

1 reference

12 December 2020

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

1 reference

12 December 2020

Heterogeneity of treatment effects: implications for guidelines, payment, and quality assessment

1 reference

12 December 2020

A comprehensive review of predictive and prognostic composite factors implicated in the heterogeneity of treatment response and outcome across disease areas

1 reference

12 December 2020

Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations.

1 reference

12 December 2020

Review of treatment response in rheumatoid arthritis: assessment of heterogeneity

1 reference

12 December 2020

Alcohol consumption and psoriatic risk: a meta-analysis of case-control studies

1 reference

12 December 2020

Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy

1 reference

12 December 2020

Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

1 reference

12 December 2020

Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis

1 reference

12 December 2020

Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.

1 reference

12 December 2020

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

1 reference

12 December 2020

Impact of comorbidities on the management of psoriasis

1 reference

12 December 2020

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

12 December 2020

Weight loss and asthma control in severely obese asthmatic females

1 reference

12 December 2020

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy

1 reference

12 December 2020

Plaque thickness and morphology in psoriasis vulgaris associated with therapeutic response

1 reference

12 December 2020

Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study

1 reference

12 December 2020

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study

1 reference

12 December 2020

Calorie restricted diet and urinary pentosidine in patients with rheumatoid arthritis

1 reference

12 December 2020

Moderate to severe psoriasis treated with infliximab - 53 patients: patients profile, efficacy and adverse effects

1 reference

12 December 2020

European S3-Guidelines on the systemic treatment of psoriasis vulgaris

1 reference

12 December 2020

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

1 reference

12 December 2020

A review of treatment response in type 2 diabetes: assessing the role of patient heterogeneity

1 reference

12 December 2020

Comprehensive review of factors implicated in the heterogeneity of response in depression

1 reference

12 December 2020

Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience

1 reference

12 December 2020

Efficacy of etanercept in an integrated multistudy database of patients with psoriasis

1 reference

12 December 2020

The effect of weight on the efficacy of biologic therapy in patients with psoriasis

1 reference

12 December 2020

Identifiers

DOI

10.1038/JID.2013.326

1 reference

11 September 2017

1 reference